444 related articles for article (PubMed ID: 10523062)
1. Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders.
Nutt DJ; Forshall S; Bell C; Rich A; Sandford J; Nash J; Argyropoulos S
Eur Neuropsychopharmacol; 1999 Jul; 9 Suppl 3():S81-6. PubMed ID: 10523062
[TBL] [Abstract][Full Text] [Related]
2. Spotlight on paroxetine in psychiatric disorders in adults.
Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
[TBL] [Abstract][Full Text] [Related]
3. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review.
Vaswani M; Linda FK; Ramesh S
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):85-102. PubMed ID: 12551730
[TBL] [Abstract][Full Text] [Related]
4. The role of serotonin in panic, anxiety and depression.
Deakin JF
Int Clin Psychopharmacol; 1998 Apr; 13 Suppl 4():S1-5. PubMed ID: 9690958
[TBL] [Abstract][Full Text] [Related]
5. [Clomipramine and other serotonin reuptake inhibitors in the treatment of depressed mood, anxiety and impaired impulse control].
Eriksson E
Psychiatr Pol; 1994; 28(5):601-12. PubMed ID: 7991713
[TBL] [Abstract][Full Text] [Related]
6. [Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?].
Möller HJ; Bauer M; Fritze J; Haen E; Laux G; Müller WE; Rüther E
MMW Fortschr Med; 2005 Jan; 147(3):43-5. PubMed ID: 15727113
[TBL] [Abstract][Full Text] [Related]
7. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder.
Hood SD; Broyd A; Robinson H; Lee J; Hudaib AR; Hince DA
J Psychopharmacol; 2017 Dec; 31(12):1615-1623. PubMed ID: 29095069
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors in mixed anxiety-depression.
Berk M
Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S41-5. PubMed ID: 11110018
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of selective serotonin reuptake inhibitor (SSRI) in the treatment of depression].
Semba J
Nihon Yakurigaku Zasshi; 2000 Aug; 116(2):79-84. PubMed ID: 10976459
[TBL] [Abstract][Full Text] [Related]
10. Where are we going with SSRIs?
Isaac M
Eur Neuropsychopharmacol; 1999 Jul; 9 Suppl 3():S101-6. PubMed ID: 10523065
[TBL] [Abstract][Full Text] [Related]
11. Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine.
den Boer JA; Westenberg HG; De Leeuw AS; van Vliet IM
Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():47-52. PubMed ID: 7622824
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A
Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
[TBL] [Abstract][Full Text] [Related]
13. Serotonergic and noradrenergic reuptake inhibitors: prediction of clinical effects from in vitro potencies.
Frazer A
J Clin Psychiatry; 2001; 62 Suppl 12():16-23. PubMed ID: 11430614
[TBL] [Abstract][Full Text] [Related]
14. The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?
Ribot R; Ouyang B; Kanner AM
Epilepsy Behav; 2017 May; 70(Pt A):5-9. PubMed ID: 28407526
[TBL] [Abstract][Full Text] [Related]
15. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors.
Zohar J; Westenberg HG
Acta Psychiatr Scand Suppl; 2000; 403():39-49. PubMed ID: 11019934
[TBL] [Abstract][Full Text] [Related]
16. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH
Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005
[TBL] [Abstract][Full Text] [Related]
17. SSRIs and SNRIs: broad spectrum of efficacy beyond major depression.
Gorman JM; Kent JM
J Clin Psychiatry; 1999; 60 Suppl 4():33-8; discussion 39. PubMed ID: 10086481
[TBL] [Abstract][Full Text] [Related]
18. SSRIs in anxious-agitated depression: a post-hoc analysis of 279 patients.
Filteau MJ; Baruch P; Lapierre YD; Bakish D; Blanchard A
Int Clin Psychopharmacol; 1995 Mar; 10(1):51-4. PubMed ID: 7622805
[TBL] [Abstract][Full Text] [Related]
19. The use of tryptophan depletion to evaluate central serotonin function in depression and other neuropsychiatric disorders.
Salomon RM; Miller HL; Delgado PL; Charney D
Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():41-6. PubMed ID: 8201246
[TBL] [Abstract][Full Text] [Related]
20. [Biological basis of anxiety disorders and serotonergic anxiolytics].
Inoue T; Izumi T; Li XB; Huang JZ; Kitaichi Y; Nakagawa S; Koyama T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Jun; 24(3):125-31. PubMed ID: 15291241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
